| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |